Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Chronic Noncancer Pain Management: Systemic Inequities of Access.

Soh ED, Portanova J.

J Gerontol Nurs. 2017 Oct 1;43(10):4-6. doi: 10.3928/00989134-20170914-01. No abstract available.

PMID:
28945264
2.

Ethnic Differences in Advance Directive Completion and Care Preferences: What Has Changed in a Decade?

Portanova J, Ailshire J, Perez C, Rahman A, Enguidanos S.

J Am Geriatr Soc. 2017 Jun;65(6):1352-1357. doi: 10.1111/jgs.14800. Epub 2017 Mar 9.

3.

It isn't like this on TV: Revisiting CPR survival rates depicted on popular TV shows.

Portanova J, Irvine K, Yi JY, Enguidanos S.

Resuscitation. 2015 Nov;96:148-50. doi: 10.1016/j.resuscitation.2015.08.002. Epub 2015 Aug 19.

PMID:
26296584
4.

The provision of home-based palliative care for those with advanced heart failure.

Enguidanos S, Portanova J.

Curr Opin Support Palliat Care. 2014 Mar;8(1):4-8. doi: 10.1097/SPC.0000000000000024. Review.

PMID:
24316851
5.

Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.

Morris DL, O'Neil SP, Devraj RV, Portanova JP, Gilles RW, Gross CJ, Curtiss SW, Komocsar WJ, Garner DS, Happa FA, Kraus LJ, Nikula KJ, Monahan JB, Selness SR, Galluppi GR, Shevlin KM, Kramer JA, Walker JK, Messing DM, Anderson DR, Mourey RJ, Whiteley LO, Daniels JS, Yang JZ, Rowlands PC, Alden CL, Davis JW 2nd, Sagartz JE.

Toxicol Pathol. 2010 Jun;38(4):606-18. doi: 10.1177/0192623310367807. Epub 2010 May 6.

PMID:
20448081
6.

Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase.

Walker JK, Selness SR, Devraj RV, Hepperle ME, Naing W, Shieh H, Kurambail R, Yang S, Flynn DL, Benson AG, Messing DM, Dice T, Kim T, Lindmark RJ, Monahan JB, Portanova J.

Bioorg Med Chem Lett. 2010 Apr 15;20(8):2634-8. doi: 10.1016/j.bmcl.2010.02.047. Epub 2010 Feb 14.

PMID:
20227876
7.

SD0006: a potent, selective and orally available inhibitor of p38 kinase.

Burnette BL, Selness S, Devraj R, Jungbluth G, Kurumbail R, Stillwell L, Anderson G, Mnich S, Hirsch J, Compton R, De Ciechi P, Hope H, Hepperle M, Keith RH, Naing W, Shieh H, Portanova J, Zhang Y, Zhang J, Leimgruber RM, Monahan J.

Pharmacology. 2009;84(1):42-60. doi: 10.1159/000227286. Epub 2009 Jul 4.

8.

Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.

Mbalaviele G, Anderson G, Jones A, De Ciechi P, Settle S, Mnich S, Thiede M, Abu-Amer Y, Portanova J, Monahan J.

J Pharmacol Exp Ther. 2006 Jun;317(3):1044-53. Epub 2006 Feb 24.

PMID:
16501068
9.

CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.

Chen Y, Zhang J, Moore SA, Ballas ZK, Portanova JP, Krieg AM, Berg DJ.

Int Immunol. 2001 Aug;13(8):1013-20.

PMID:
11470771
10.

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis.

Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, Dubinett SM.

J Immunol. 2000 Jan 1;164(1):361-70.

11.

Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.

Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson PC.

J Pharmacol Exp Ther. 1997 Dec;283(3):1069-75.

PMID:
9399978
12.

Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.

Monahan J, Siegel N, Keith R, Caparon M, Christine L, Compton R, Cusik S, Hirsch J, Huynh M, Devine C, Polazzi J, Rangwala S, Tsai B, Portanova J.

J Immunol. 1997 Oct 15;159(8):4024-34.

PMID:
9378992
13.

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo.

Portanova JP, Zhang Y, Anderson GD, Hauser SD, Masferrer JL, Seibert K, Gregory SA, Isakson PC.

J Exp Med. 1996 Sep 1;184(3):883-91.

14.

Di- and trinucleotide target preferences of somatic mutagenesis in normal and autoreactive B cells.

Smith DS, Creadon G, Jena PK, Portanova JP, Kotzin BL, Wysocki LJ.

J Immunol. 1996 Apr 1;156(7):2642-52.

PMID:
8786330
15.

Rapid and selective induction of blood eosinophilia in guinea pigs by recombinant human interleukin 5.

Portanova JP, Christine LJ, Rangwala SH, Compton RP, Hirsch JL, Smith WG, Monahan JB.

Cytokine. 1995 Nov;7(8):775-83.

PMID:
8664444
16.

Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2.

Mnich SJ, Veenhuizen AW, Monahan JB, Sheehan KC, Lynch KR, Isakson PC, Portanova JP.

J Immunol. 1995 Nov 1;155(9):4437-44.

PMID:
7594605
17.

Evaluation of Misoprostol and Analogs as Inhibitors of T-Cell Activation.

Mnich SJ, Collins PW, Gasiecki AF, Kramer SW, Gregory SA, Portanova JP.

Am J Ther. 1995 Sep;2(9):648-659.

PMID:
11854842
18.

An early post-mutational selection event directs expansion of autoreactive B cells in murine lupus.

Portanova JP, Creadon G, Zhang X, Smith DS, Kotzin BL, Wysocki LJ.

Mol Immunol. 1995 Feb;32(2):117-35.

PMID:
7870064
19.

Genetic contributions to T-cell recognition in murine lupuslike autoimmune disease.

Portanova JP, Babcock SK, Palmer E, Kotzin BL.

Immunol Ser. 1991;54:65-95. Review. No abstract available.

PMID:
1954280
20.

Histone autoantigens in murine lupus. Definition of a major epitope within an accessible region of chromatin.

Portanova JP, Cheronis JC, Blodgett JK, Kotzin BL.

J Immunol. 1990 Jun 15;144(12):4633-40.

PMID:
1693638
21.

Self-reactive T cells in murine lupus: analysis of genetic contributions and development of self-tolerance.

Kotzin BL, Herron LR, Babcock SK, Portanova JP, Palmer E.

Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 2):S35-46.

PMID:
2571438
22.

Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease.

Portanova JP, Ebling FM, Hammond WS, Hahn BH, Kotzin BL.

J Immunol. 1988 Nov 15;141(10):3370-6.

PMID:
3263424
23.
25.

Lupus-like autoimmunity in murine graft-versus-host disease.

Portanova JP, Kotzin BL.

Concepts Immunopathol. 1988;6:119-40. Review. No abstract available.

PMID:
3292048
26.

Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions.

Portanova JP, Arndt RE, Tan EM, Kotzin BL.

J Immunol. 1987 Jan 15;138(2):446-51.

PMID:
2432124
27.

Interleukin 2 is a proliferative signal for B cells from autoimmune mice.

Lehmann KR, Kotzin BL, Portanova JP, Santoro TJ.

Eur J Immunol. 1986 Sep;16(9):1105-10.

PMID:
3093246
28.

Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.

Portanova JP, Claman HN, Kotzin BL.

J Immunol. 1985 Dec;135(6):3850-6.

PMID:
3877758
29.

Rabbits immunized with mixtures of staphylococcal protein A and autologous IgG produce anti-human IgG antibodies.

Portanova JP, Abeyounis CJ, Milgrom F.

Proc Soc Exp Biol Med. 1985 Nov;180(2):369-74.

PMID:
2413464
31.

Monoclonal anti-histone autoantibodies derived from murine models of lupus.

Kotzin BL, Lafferty JA, Portanova JP, Rubin RL, Tan EM.

J Immunol. 1984 Nov;133(5):2554-9.

PMID:
6332855
32.

Distribution of anti-histone-antibody-secreting cells in NZB/NZW mice.

Portanova JP, Kotzin BL, Coleman EA, Claman HN.

Cell Immunol. 1984 Sep;87(2):485-93.

PMID:
6380766
33.

Quinidine-induced lupus erythematosus.

West SG, McMahon M, Portanova JP.

Ann Intern Med. 1984 Jun;100(6):840-2.

PMID:
6372564
34.

Reactivity of anti-histone antibodies induced by procainamide and hydralazine.

Portanova JP, Rubin RL, Joslin FG, Agnello VD, Tan EM.

Clin Immunol Immunopathol. 1982 Oct;25(1):67-79. No abstract available.

PMID:
6983942
35.

Drug-induced lupus: clinical and serological studies.

Harmon CE, Portanova JP.

Clin Rheum Dis. 1982 Apr;8(1):121-35. Review. No abstract available.

PMID:
6811188
36.

The role of histones as nuclear autoantigens in drug-related lupus erythematosus.

Tan EM, Portanova JP.

Arthritis Rheum. 1981 Aug;24(8):1064-9.

PMID:
7025842
37.

The use of staphylococcal protein A in the mixed agglutination test.

Portanova JP, Abeyounis CJ, Milgrom F.

J Immunol Methods. 1979;25(3):247-54.

PMID:
762436
38.

Usefulness of N-ethylmaleimide in the identification of 75Se-labeled selenocysteine.

Portanova JP, Shrift A.

J Chromatogr. 1977 Sep 21;139(2):391-4. No abstract available.

PMID:
893624

Supplemental Content

Loading ...
Support Center